133 related articles for article (PubMed ID: 7562405)
1. Penetration of minoxidil from ethanol/propylene glycol solutions: effect of application volume and occlusion.
Tata S; Flynn GL; Weiner ND
J Pharm Sci; 1995 Jun; 84(6):688-91. PubMed ID: 7562405
[TBL] [Abstract][Full Text] [Related]
2. Relative influence of ethanol and propylene glycol cosolvents on deposition of minoxidil into the skin.
Tata S; Weiner N; Flynn G
J Pharm Sci; 1994 Oct; 83(10):1508-10. PubMed ID: 7884676
[TBL] [Abstract][Full Text] [Related]
3. Drug and vehicle deposition from topical applications: use of in vitro mass balance technique with minoxidil solutions.
Tsai JC; Cappel MJ; Flynn GL; Weiner ND; Kreuter J; Ferry JJ
J Pharm Sci; 1992 Aug; 81(8):736-43. PubMed ID: 1403715
[TBL] [Abstract][Full Text] [Related]
4. Drug and vehicle deposition from topical applications: localization of minoxidil within skin strata of the hairless mouse.
Tsai JC; Weiner N; Flynn GL; Ferry JJ
Skin Pharmacol; 1994; 7(5):262-9. PubMed ID: 8054208
[TBL] [Abstract][Full Text] [Related]
5. Effect of tocopheryl polyethylene glycol succinate on the percutaneous penetration of minoxidil from water/ethanol/polyethylene glycol 400 solutions.
Sheu MT; Wu AB; Lin KP; Shen CH; Ho HO
Drug Dev Ind Pharm; 2006 Jun; 32(5):595-607. PubMed ID: 16720414
[TBL] [Abstract][Full Text] [Related]
6. Influence of application time and formulation reapplication on the delivery of minoxidil through hairless mouse skin as measured in Franz diffusion cells.
Tsai JC; Flynn GL; Weiner N; Ferry JJ
Skin Pharmacol; 1994; 7(5):270-7. PubMed ID: 8054209
[TBL] [Abstract][Full Text] [Related]
7. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
Balakrishnan P; Shanmugam S; Lee WS; Lee WM; Kim JO; Oh DH; Kim DD; Kim JS; Yoo BK; Choi HG; Woo JS; Yong CS
Int J Pharm; 2009 Jul; 377(1-2):1-8. PubMed ID: 19394413
[TBL] [Abstract][Full Text] [Related]
8. Relative uptake of minoxidil into appendages and stratum corneum and permeation through human skin in vitro.
Grice JE; Ciotti S; Weiner N; Lockwood P; Cross SE; Roberts MS
J Pharm Sci; 2010 Feb; 99(2):712-8. PubMed ID: 19544367
[TBL] [Abstract][Full Text] [Related]
9. Penetration of corticosteroids through the skin in relation to the vehicle.
Ponec M
Dermatologica; 1976; 152 Suppl 1():37-46. PubMed ID: 955237
[TBL] [Abstract][Full Text] [Related]
10. New ethanol and propylene glycol free gel formulations containing a minoxidil-methyl-β-cyclodextrin complex as promising tools for alopecia treatment.
Lopedota A; Cutrignelli A; Denora N; Laquintana V; Lopalco A; Selva S; Ragni L; Tongiani S; Franco M
Drug Dev Ind Pharm; 2015 May; 41(5):728-36. PubMed ID: 24650036
[TBL] [Abstract][Full Text] [Related]
11. Transdermal delivery of mixnoxidil with block copolymer nanoparticles.
Shim J; Seok Kang H; Park WS; Han SH; Kim J; Chang IS
J Control Release; 2004 Jul; 97(3):477-84. PubMed ID: 15212879
[TBL] [Abstract][Full Text] [Related]
12. Effects of polyoxypropylene 15 stearyl ether and propylene glycol on percutaneous penetration rate of diflorasone diacetate.
Turi JS; Danielson D; Woltersom JW
J Pharm Sci; 1979 Mar; 68(3):275-80. PubMed ID: 423113
[TBL] [Abstract][Full Text] [Related]
13. Use of glycerin in topical minoxidil solutions for patients allergic to propylene glycol.
Fisher AA
Cutis; 1990 Feb; 45(2):81-2. PubMed ID: 2138072
[No Abstract] [Full Text] [Related]
14. In vitro permeation of carvedilol through porcine skin: effect of vehicles and penetration enhancers.
Gannu R; Vishnu YV; Kishan V; Rao YM
PDA J Pharm Sci Technol; 2008; 62(4):256-63. PubMed ID: 19174954
[TBL] [Abstract][Full Text] [Related]
15. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil.
Mura S; Manconi M; Sinico C; Valenti D; Fadda AM
Int J Pharm; 2009 Oct; 380(1-2):72-9. PubMed ID: 19589377
[TBL] [Abstract][Full Text] [Related]
16. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil: in vitro evaluation of drug permeation by infrared spectroscopy.
Mura S; Manconi M; Fadda AM; Sala MC; Perricci J; Pini E; Sinico C
Pharm Dev Technol; 2013; 18(6):1339-45. PubMed ID: 22563642
[TBL] [Abstract][Full Text] [Related]
17. Minoxidil-containing dosage forms: skin retention and after-rinsing hair-growth promotion.
Kim JC; Lee MH; Rang MJ
Drug Deliv; 2003; 10(2):119-23. PubMed ID: 12746058
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous effects of tocopheryl polyethylene glycol succinate (TPGS) on local hair growth promotion and systemic absorption of topically applied minoxidil in a mouse model.
Chen CH; Sheu MT; Wu AB; Lin KP; Ho HO
Int J Pharm; 2005 Dec; 306(1-2):91-8. PubMed ID: 16253450
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous penetration of acyclovir through excised hairless mouse and rat skin: effect of vehicle and percutaneous penetration enhancer.
Okamoto H; Muta K; Hashida M; Sezaki H
Pharm Res; 1990 Jan; 7(1):64-8. PubMed ID: 2300538
[TBL] [Abstract][Full Text] [Related]
20. Topical minoxidil for hair regrowth.
Vanderveen EE; Ellis CN; Kang S; Case P; Headington JT; Voorhees JJ; Swanson NA
J Am Acad Dermatol; 1984 Sep; 11(3):416-21. PubMed ID: 6384289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
